CR
Christopher Ryan Sullivan sold $179K of AVTX stock
Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX), sold 10,185 shares of AVTX stock worth $179K, per an SEC Form 4 filed Sep 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 10, 2026, 1 day before it was made public.
AVTX has moved -57.1% since the trade date, from $17.18 to $7.37 (Nov 16, 2026 close).
- Traded
- Sep 10, 2026
- Disclosed
- Sep 11, 2026
- Filing delay
- 1 day
- Price since
- -57.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4